Entrada Therapeutics, Inc. (TRDA)
10.46
+0.51
(+5.13%)
USD |
NASDAQ |
Jan 13, 16:00
10.45
-0.01
(-0.10%)
Pre-Market: 20:00
Entrada Therapeutics EPS Diluted (Quarterly): -1.064 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Kodiak Sciences, Inc. | -1.163 |
| Janux Therapeutics, Inc. | -0.392 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -44.13M |
| Revenue (Quarterly) | 1.614M |
| Total Expenses (Quarterly) | 45.75M |
| Enterprise Value | 125.33M |
| Gross Profit Margin (Quarterly) | 25.65% |
| Profit Margin (Quarterly) | -2.73K% |
| Earnings Yield | -23.93% |
| Normalized Earnings Yield | -23.62 |